Abdul Muktadir, chairman and managing director of Incepta Pharmaceuticals Ltd, has been elected president of the Bangladesh ...

The global pharmaceutical company Teva announced a strategic partnership with Kerry Pharma, a subsidiary of the Kerry ...

General Meeting of BAPI was held yesterday (15 March), where the election for the new executive committee took place ...

Among the 50 stocks in the Nifty index, 38 were trading in the green, while 12 were in the red. Shares of Vodafone Idea, ...

Kerry Logistics Network Limited ('KLN'; Stock Code 0636.HK), through its subsidiary, Kerry Pharma, and Teva Pharmaceutical Hong Kong Limited ('Teva') entered into an exclusive agreement for ...

I'm the Senior Analyst for the Specialty Pharmaceuticals sector for Barclays ... sure when it comes to networking capital, CapEx, general capital allocation. So we keep applying it to AUSTEDO ...

For instance, Gujarat-based drugmaker Intas Pharmaceuticals Ltd, which counts PE firm ChrysCapital ... Last year, two homegrown healthcare companies, backed by PE firms General Atlantic and TPG, ...

Q4 2024 Earnings Call Transcript March 13, 2025 aTyr Pharma, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.23. Operator: Good afternoon, ladies and gentlemen, and ...

HC Wainwright reissued their buy rating on shares of KalVista Pharmaceuticals (NASDAQ:KALV – Free Report) in a research report released on Friday,Benzinga reports. The firm currently has a $20.00 ...

PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology ...

KalVista Pharmaceuticals (NASDAQ:KALV – Get Free Report)‘s stock had its “buy” rating restated by research analysts at Needham & Company LLC in a research note issued on Thursday,Benzinga reports.

It is a positive sign for investors that directors of several well-known listed firms are purchasing their own shares, ...